Cytokinetics, Incorporated Share Price

Cytokinetics, Incorporated Share Price

NASDAQ: CYTK | Micro Cap
$56.11
-$2.56 (-4.36%) Last updated on 13 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Cytokinetics, Incorporated Stock Performance

Open
$58.19
Prev. Close
$58.67
Circuit Range
N/A
Day Range
$55.70 - $58.19
Year Range
$53.56 - $87.92
Volume
1,14,965
Average Traded
$56.35

Cytokinetics, Incorporated Share Price Today

As of 13 November 2026, Cytokinetics, Incorporated's share price is $56.11. The stock opened at $58.19, compared to its previous close of $58.67. During today's trading session, Cytokinetics, Incorporated's share price traded between $55.70 and $58.19, with an average price of $56.94. Over the past 52 weeks, the stock has recorded a high of $87.92 and a low of $53.56. In terms of performance, Cytokinetics, Incorporated's share price has declined by 26.90% over the last six months and is down 17.62% on a year-on-year basis.

Cytokinetics, Incorporated Share Price Chart

Line chart of the Cytokinetics, Incorporated price trend over the selected period. The price fell overall, ranging from 55.94 to 58.97, ending at 58.52.
$55.70$58.19
L
Show Current Price
H

Cytokinetics, Incorporated Stock Fundamentals & Key Indicators

Market Cap
$6.74M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-5.58
Revenue (TTM)
$88.04B
Return On Equity (TTM)
242.21%
Profit Margin
-891.59%
Debt to Equity
-3.59
Quarterly Earnings Growth YoY
-3.85%

Cytokinetics, Incorporated Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$17.76$19.36$28.62$47.56
Net Profit-$183.03-$206.03-$198.76-$190.07
Net Profit Margin-1030.57%-1064.20%-694.48%-399.64%
Income ChangeN/A-12.57%3.53%4.37%

Cytokinetics, Incorporated Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$94.59$7.53$18.47$88.04
Net Profit-$388.96-$526.24-$589.53-$784.96
Net Profit Margin-411.21%-6988.58%-3191.82%-891.59%
Income ChangeN/A-35.29%-12.03%-33.15%

About Cytokinetics, Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Cytokinetics, Incorporated Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$63.63
$56.08
-10.93%
Oct 2026
$65.48
$62.96
-4.37%
Sep 2026
$70.14
$65.84
-15.53%
Aug 2026
$76.33
$77.94
+1.15%
Jul 2026
$84.89
$77.06
-9.47%
Jun 2026
$75.92
$85.12
+10.89%
May 2026
$64.21
$76.76
+19.97%
Apr 2026
$66.44
$63.98
-2.91%
Mar 2026
$61.49
$65.90
+5.89%
Feb 2026
$62.40
$62.23
-1.56%
Jan 2026
$62.74
$63.22
-0.51%
Dec 2025
$67.03
$63.55
-6.70%

CYTK Share Price FAQs